Indian pharma firms go local seeking to end reliance on China

Contributed by NAMPA / Reuters.

By Krishna N. Das
NEW DELHI, Feb 23 (Reuters) - Indian drug companies are
looking to local makers of so-called active pharmaceutical
ingredients (API) or trying to make them in-house in a bid to
end their reliance on China as ties between the two countries
soured after a deadly border clash last June.
Though India is known as the pharmacy of the world for its
massive production capacities of both generic drugs and
vaccines, China accounted for half of its API ...